IBES
LIVE

Serial Number

99672754

Owner

Singulera Therapeutics Inc.

Attorney

Joe McKinney Muncy

Filing Date

Feb 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

IBES Trademark

Serial Number: 99672754

IBES is a trademark filed by Singulera Therapeutics Inc. on February 26, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently pending registration.

Owner Contact Info

Singulera Therapeutics Inc.

400 N. Aberdeen St, Suite 900
Chicago, IL 60642

Entity Type: 03

Trademark Details

Filing Date

February 26, 2026

Registration Date

Not Registered

Goods & Services

Syringes filled with pharmaceuticals for the treatment of osteoarthritis and other degenerative joint diseases; Syringes filled with pharmaceuticals for chronic wound healing, including non-healing ulcers; Syringes filled with immune-modulating pharmaceuticals for autoimmune diseases and transplant rejection prevention; Syringes filled with pharmaceuticals for cardiovascular diseases, including acute myocardial infarction and ischemic conditions; Syringes filled with regenerative pharmaceuticals for skin and tissue repair; Organotherapy preparations; Biological preparations for use in cell cultures for medical purposes; Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use, namely for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Pharmaceutical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system; Pharmaceutical preparations for cell therapy; Pharmaceutical preparations for gene therapy; Pharmaceutical preparations for genetically modifying human and animal cells for diagnostic and medical purposes; Pharmaceutical preparations for therapies to modulate the immune system; Pharmaceutical preparations for therapeutic delivery of nucleic acids; Medical pharmaceutical preparations containing viral vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Stem cells for medical purposes; Biological reagent for medical purposes; Opotherapy preparations; Protein preparations for medical purposes

Custom manufacturing of pharmaceuticals; Custom manufacturing of biological tissue, blood, cell and genetic material; Custom biomanufacturing of pharmaceutical preparations

Filing History

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 26, 2026 MAFR
NEW APPLICATION ENTERED
Feb 26, 2026 NWAP